Literature DB >> 7916454

Growth hormone, insulin-like growth factor-I and somatostatin in human fetus, newborn, mother plasma and amniotic fluid.

G Bona1, C Aquili, P Ravanini, M R Gallina, A C Cigolotti, M Zaffaroni, P Paniccia, F Mussa.   

Abstract

During pregnancy, organism development and its differentiation are stimulated and modulated by fetal and placental hormones. However the exact role played by all the different growth factors has not been explained yet. This study summarizes knowledge about secretion, regulation and role of GH, IGF-1 and SRIF during perinatal age. It also reports the results of researches into GH, IGF-1 and SRIF in amniotic fluid, in mothers and in newborns at delivery and at four days of age. Amniotic fluid GH levels proved significantly higher during middle pregnancy that at delivery (p < 0.001); a significant difference was also found between mean GH concentrations observed in amniotic fluid collected at delivery in preterm and full-term pregnancies. In amniotic fluid, significant reductions of SRIF and IGF-1 concentrations correspond to a sudden decrease of GH concentration during the last months of pregnancy. Fetal serum GH levels resulted higher than venous cordonal GH concentration at birth (p < 0.001). High levels of IGF-1 were found in the amniotic fluid and in the maternal plasma. These values were higher than those observed in cord blood during pregnancy or at delivery. Preterm and full-term newborns showed similar serum GH levels at birth and at the age of 4 days. Mean GH values in newborns, both at birth and at the age of 4 days, proved to be significantly higher than the values of their mothers (p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916454

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  7 in total

Review 1.  IGF-I in the clinics: Use in retinopathy of prematurity.

Authors:  Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Luca A Ramenghi; Chatarina Löfqvist; Lois E H Smith; Anna-Lena Hård
Journal:  Growth Horm IGF Res       Date:  2016-09-28       Impact factor: 2.372

Review 2.  Role of Insulinlike Growth Factor 1 in Fetal Development and in the Early Postnatal Life of Premature Infants.

Authors:  Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Luca A Ramenghi; Chatarina Löfqvist; Lois E H Smith; Anna-Lena Hård
Journal:  Am J Perinatol       Date:  2016-09-07       Impact factor: 1.862

3.  Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.

Authors:  A Hellstrom; C Perruzzi; M Ju; E Engstrom; A L Hard; J L Liu; K Albertsson-Wikland; B Carlsson; A Niklasson; L Sjodell; D LeRoith; D R Senger; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

Review 4.  Retinopathy of prematurity: the need for prevention.

Authors:  Raffael Liegl; Ann Hellström; Lois Eh Smith
Journal:  Eye Brain       Date:  2016-05-20

5.  Effect of Early Breast Milk Nutrition on Serum Insulin-Like Growth Factor-1 in Preterm Infants.

Authors:  Fatma A Alzaree; Mones M AbuShady; Mohamed Abdel Atti; Gihan A Fathy; Essam M Galal; Alaa Ali; Tahany R Elias
Journal:  Open Access Maced J Med Sci       Date:  2019-01-12

Review 6.  Placental Tissues as Biomaterials in Regenerative Medicine.

Authors:  Annelise Roy; Morgan Mantay; Courtney Brannan; Sarah Griffiths
Journal:  Biomed Res Int       Date:  2022-04-21       Impact factor: 3.246

Review 7.  IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

Authors:  Ann Hellstrom; David Ley; Boubou Hallberg; Chatarina Lofqvist; Ingrid Hansen-Pupp; Luca A Ramenghi; Jan Borg; Lois E H Smith; Anna-Lena Hard
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.